Fulgent Genetics Price to Free Cash Flow Ratio 2015-2024 | FLGT
Historical price to free cash flow ratio values for Fulgent Genetics (FLGT) since 2015.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Fulgent Genetics Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-13 | 20.29 | 0.00 | |
| 2024-12-31 | 18.47 | $-0.63 | 0.00 |
| 2024-09-30 | 21.73 | $-0.91 | 0.00 |
| 2024-06-30 | 19.62 | $0.42 | 47.24 |
| 2024-03-31 | 21.70 | $0.63 | 34.26 |
| 2023-12-31 | 28.91 | $0.19 | 154.60 |
| 2023-09-30 | 26.74 | $0.68 | 39.04 |
| 2023-06-30 | 37.03 | $1.07 | 34.53 |
| 2023-03-31 | 31.22 | $1.40 | 22.23 |
| 2022-12-31 | 29.78 | $7.59 | 3.92 |
| 2022-09-30 | 38.12 | $9.08 | 4.20 |
| 2022-06-30 | 54.53 | $13.18 | 4.14 |
| 2022-03-31 | 62.41 | $15.28 | 4.09 |
| 2021-12-31 | 100.59 | $16.62 | 6.05 |
| 2021-09-30 | 89.95 | $18.83 | 4.78 |
| 2021-06-30 | 92.23 | $14.14 | 6.52 |
| 2021-03-31 | 96.62 | $11.56 | 8.35 |
| 2020-12-31 | 52.10 | $4.39 | 11.88 |
| 2020-09-30 | 40.04 | $-0.23 | 0.00 |
| 2020-06-30 | 16.00 | $-0.01 | 0.00 |
| 2020-03-31 | 10.76 | $0.21 | 51.83 |
| 2019-12-31 | 12.90 | $0.23 | 55.68 |
| 2019-09-30 | 10.39 | $0.29 | 36.01 |
| 2019-06-30 | 6.68 | $0.03 | 218.30 |
| 2019-03-31 | 5.95 | $-0.01 | 0.00 |
| 2018-12-31 | 3.17 | $-0.20 | 0.00 |
| 2018-09-30 | 3.93 | $-0.37 | 0.00 |
| 2018-06-30 | 4.14 | $-0.43 | 0.00 |
| 2018-03-31 | 4.00 | $-0.44 | 0.00 |
| 2017-12-31 | 4.38 | $-0.23 | 0.00 |
| 2017-09-30 | 4.79 | $-0.03 | 0.00 |
| 2017-06-30 | 6.39 | $0.08 | 82.99 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.613B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.281B | 54.26 |
| Hims & Hers Health (HIMS) | United States | $12.358B | 128.40 |
| Tempus AI (TEM) | United States | $10.796B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.614B | 72.09 |
| IRhythm Technologies (IRTC) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $3.055B | 208.83 |
| Enovis (ENOV) | United States | $2.089B | 11.65 |
| Clover Health Investments (CLOV) | United States | $1.773B | 0.00 |
| Schrodinger (SDGR) | United States | $1.765B | 0.00 |
| Phreesia (PHR) | United States | $1.531B | 0.00 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| Omnicell (OMCL) | United States | $1.286B | 22.69 |
| 10x Genomics (TXG) | United States | $1.161B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.515B | 154.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.441B | 0.00 |
| TruBridge (TBRG) | United States | $0.395B | 875.67 |
| Claritev (CTEV) | United States | $0.353B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.315B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.151B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |